Nivolumab-induced pneumonitis and cardiopathy in a patient with relapsed Hodgkin's lymphoma.

Early and effective diagnosis of immune-related adverse events through the search for predictive biomarkers like drug factors and individual risk factors will allow targeted surveillance leading to a better tolerance.